Antipsychotics in pediatric and adolescent patients: A review of comparative safety data
- 1 January 2012
- journal article
- research article
- Published by Elsevier in Journal of Affective Disorders
- Vol. 138, S22-S30
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Antipsychotic drug toxicology in childrenExpert Opinion on Drug Metabolism & Toxicology, 2011
- National Trends in Child and Adolescent Psychotropic Polypharmacy in Office-Based Practice, 1996-2007Journal of the American Academy of Child & Adolescent Psychiatry, 2010
- Cardiometabolic Risk of Second-Generation Antipsychotic Medications During First-Time Use in Children and AdolescentsJAMA, 2009
- One-Year Incidence Rates of Tardive Dyskinesia in Children and Adolescents Treated with Second-Generation Antipsychotics: A Systematic ReviewJournal of Child and Adolescent Psychopharmacology, 2007
- Atypical antipsychotic-induced diabetes mellitus in child and adolescent psychiatry.CNS Drugs, 2007
- Endocrine and Metabolic Adverse Effects of Psychotropic Medications in Children and AdolescentsJournal of the American Academy of Child & Adolescent Psychiatry, 2006
- Management Options for Bipolar Disorder in Children and AdolescentsPediatric Drugs, 2005
- Electrocardiographic Changes in Children and Adolescents Treated With Ziprasidone: A Prospective StudyJournal of the American Academy of Child & Adolescent Psychiatry, 2005
- Clinical effectiveness of new generation antipsychotics in adolescent patientsEuropean Neuropsychopharmacology, 2004
- EEG Abnormalities During Treatment With Typical and Atypical AntipsychoticsAmerican Journal of Psychiatry, 2002